STADA Pharmaceuticals CEO Says Would Not Block a Good Takeover Bid
Reuters -- Generic drugmaker Stada (STAGn.DE), which sources say is in the sights of U.S. drugs major Pfizer (PFE.N), would not block a takeover bid that was attractive for shareholders, its chief executive said.